BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9139487)

  • 1. Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice.
    Konishi E; Win KS; Kurane I; Mason PW; Shope RE; Ennis FA
    Vaccine; 1997 Feb; 15(3):281-6. PubMed ID: 9139487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.
    Konishi E; Yamaoka M; Khin-Sane-Win ; Kurane I; Takada K; Mason PW
    J Virol; 1999 Jul; 73(7):5527-34. PubMed ID: 10364301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes.
    Konishi E; Kurane I; Mason PW; Innis BL; Ennis FA
    Am J Trop Med Hyg; 1995 Sep; 53(3):278-83. PubMed ID: 7573713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.
    Konishi E; Kurane I; Mason PW; Shope RE; Kanesa-Thasan N; Smucny JJ; Hoke CH; Ennis FA
    Vaccine; 1998 May; 16(8):842-9. PubMed ID: 9627942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice.
    Konishi E; Ajiro N; Nukuzuma C; Mason PW; Kurane I
    Vaccine; 2003 Sep; 21(25-26):3675-83. PubMed ID: 12922097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice.
    Zhang Y; Han JC; Jing J; Liu H; Zhang H; Li ZH; Jin NY; Lu HJ
    Vector Borne Zoonotic Dis; 2020 Oct; 20(10):788-796. PubMed ID: 32584657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes.
    Konishi E; Yamaoka M; Khin-Sane-Win ; Kurane I; Mason PW
    J Virol; 1998 Jun; 72(6):4925-30. PubMed ID: 9573260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.
    Aihara H; Takasaki T; Toyosaki-Maeda T; Suzuki R; Okuno Y; Kurane I
    Viral Immunol; 2000; 13(2):179-86. PubMed ID: 10892998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
    Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
    Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.
    Hunt AR; Cropp CB; Chang GJ
    J Virol Methods; 2001 Sep; 97(1-2):133-49. PubMed ID: 11483224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
    Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
    Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.
    Kuwahara M; Konishi E
    Clin Vaccine Immunol; 2010 Oct; 17(10):1560-6. PubMed ID: 20668137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.
    Zhao Z; Wakita T; Yasui K
    J Virol; 2003 Apr; 77(7):4248-60. PubMed ID: 12634382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.